Guardant Health, Inc. (NASDAQ:GH) reached 180.36% versus a 1-year low price of $27.04. The stock was last seen 6.03% higher, reaching at $75.81 on 5/23/2019. At a recent session, the prices were hovering between $71.05 and $75.125. This company shares are 11.79% off its target price of $84.75 and the current market capitalization stands at $6.64B. The recent change has given its price a 2.3% lead over SMA 50 and -28.87% deficit over its 52-week high. The stock witnessed 15.74% gains, 40.05% gains and 125.49% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found GH’s volatility during a week at 5.45% and during a month it has been found around 5.73%.

Guardant Health, Inc. (GH) Top Holders

Institutional investors currently hold around $4.31 billion or 82.4% in GH stock. Look at its top three institutional owners: Sb Investment Advisers (Uk) Ltd owns $1.99 billion in Guardant Health, Inc., which represents roughly 29.99% of the company’s market cap and approximately 46.19% of the institutional ownership. Similar statistics are true for the second largest owner, Sc Us (Ttgp), Ltd., which owns 7,784,052 shares of the stock are valued at $556.56 million. The third largest holder is Vk Services, Llc, which currently holds $510.62 million worth of this stock and that ownership represents nearly 7.69% of its market capitalization.

Guardant Health, Inc. 13F Filings

At the end of March reporting period, 102 institutional holders increased their position in Guardant Health, Inc. (NASDAQ:GH) by some 3,917,021 shares, 46 decreased positions by 3,255,232 and 9 held positions by 53,118,710. That puts total institutional holdings at 60,290,963 shares, according to SEC filings. The stock grabbed 72 new institutional investments totaling 1,013,455 shares while 10 institutional investors sold out their entire positions totaling 1,050,794 shares.

Guardant Health, Inc. (NASDAQ:GH) Insider Trades

Multiple company employees have indulged in significant insider trading. Guardant Health, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Medical Officer Lanman Richard B. has sold 1,690 shares of Guardant Health, Inc. (GH) in the trading session dated May. 16, 2019. These shares are worth $135,200 and were traded at $80 each. The SEC filing shows that Eltoukhy Helmy performed a sale of 78,660 shares. The CEO disposed these shares by way of transaction on May. 14, 2019. The company’s shares were given away at $72.34 per share worth to an income of some $5,690,264 to the account of Eltoukhy Helmy.

CFO, BERTOCCI DEREK A, sold 18,562 common shares of Guardant Health, Inc. (GH) in the open market. In a transaction dated May. 10, 2019, the shares were put up for sale at an average price of $76.3, raking in a sum of $1,416,281. After this sale, 92,875 common shares of GH are directly owned by the insider, with total stake valued at $7,040,854.

In the transaction dated May. 08, 2019, a great number of shares sold came courtesy the Chief Legal Officer; Wiley Michael J disposed a total of 80,000 shares at an average price of $65.96, amounting to approximately $5,276,800. The insider now directly owns 265,358 shares worth $20,116,790.

Guardant Health, Inc. (GH) Analyst Guide

Several analysts have released their opinion on Guardant Health, Inc. (NASDAQ:GH), with 3 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.4 average brokerage recommendation [T1].